SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will moderate the panel "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
News | 03. 21. 2013
Art Pappas will moderate a panel titled, "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
